The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.
about
Afferent arteriolar vasodilator effect of adenosine predominantly involves adenosine A2B receptor activationProduction of leukotrienes in a model of focal cerebral ischaemia in the ratAdenosine and ischemic preconditioning.A(2A) adenosine receptors in human peripheral blood cellsEffect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slicesRole of A(2A)-adenosine receptor activation for ATP-mediated coronary vasodilation in guinea-pig isolated heartA3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats.Expression and characterization of purinergic receptors in rat middle meningeal artery-potential role in migraineSelective inhibition of KCa3.1 channels mediates adenosine regulation of the motility of human T cellsRole of A2B adenosine receptors in regulation of paracrine functions of stem cell antigen 1-positive cardiac stromal cells.A2A Adenosine Receptor Antagonism Reverts the Blood-Brain Barrier Dysfunction Induced by Sleep Restriction.Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients.Host A(2B) adenosine receptors promote carcinoma growthMechanisms of the adenosine A2A receptor-induced sensitization of esophageal C fibersGDNF control of the glutamatergic cortico-striatal pathway requires tonic activation of adenosine A receptors.Purinergic A2b Receptor Activation by Extracellular Cues Affects Positioning of the Centrosome and Nucleus and Causes Reduced Cell Migration.Brain-derived neurotrophic factor (BDNF) enhances GABA transport by modulating the trafficking of GABA transporter-1 (GAT-1) from the plasma membrane of rat cortical astrocytes.Ticagrelor potentiates adenosine-induced stimulation of neutrophil chemotaxis and phagocytosisEffects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes.Adenosine A(2A) Receptor Binding Profile of Two Antagonists, ST1535 and KW6002: Consideration on the Presence of Atypical Adenosine A(2A) Binding Sites.Adenosine induces growth-cone turning of sensory neurons.Enhancement of LTP in aged rats is dependent on endogenous BDNF.Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils.1-Phenyl-6,7,8,9-hexa-hydro-1H,5H-cyclo-hepta-[1',2':2,3]pyrido[6,5-c]pyrazol-4-amine: a new tacrine analogue.Role of K+ channels in A2A adenosine receptor-mediated dilation of the pressurized renal arcuate artery.Adenosine A2A receptor activation is determinant for BDNF actions upon GABA and glutamate release from rat hippocampal synaptosomes.Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices.Characterisation of endogenous A2A and A2B receptor-mediated cyclic AMP responses in HEK 293 cells using the GloSensor™ biosensor: Evidence for an allosteric mechanism of action for the A2B-selective antagonist PSB 603.Adenosine A2A Receptor Blockade Modulates Glucocorticoid-Induced Morphological Alterations in Axons, But Not in Dendrites, of Hippocampal Neurons.Ability of γδ T cells to modulate the Foxp3 T cell response is dependent on adenosine.High level expression of A2ARs is required for the enhancing function, but not for the inhibiting function, of γδ T cells in the autoimmune responses of EAU.
P2860
Q28282214-0E654B93-773E-4A81-96AD-B6B914644638Q28345776-1D7C2896-34BA-4A8E-AA79-F31E7489A7DCQ33801903-A43A72DA-F240-4A37-96F7-BE83B6E34933Q33849871-595E09D4-3FFE-463E-8580-FB7C52B1C1A0Q35041668-6629B2F7-3579-43EF-8C9B-96AF5E5D117AQ35042386-D15C1DBB-DBC6-49B7-9A7F-FC9DC8A73D32Q35235736-DEACD769-0B1E-4843-9D32-9EEEEBB4E34BQ35284591-D23B5BA0-A6B9-4347-8443-12C711A22182Q35557998-D74E2705-93BB-47FF-BFBF-8E50764035DBQ35996708-B5E66F85-B65A-454B-B943-D0538C5CC146Q36205753-B8B069DE-8D08-4BF7-AB78-83D10BD87712Q36528787-30154A57-5C94-4499-A5FC-2CFBD833C09FQ36840284-B5529EBE-EEF7-450D-8B25-4609BD999418Q37148733-F8DC2820-84CD-49D4-9198-71EF434C51F2Q37176918-168D2BE8-12EE-4043-9196-4FEB16ECC38FQ38768350-8F3762B4-7300-4C3B-93B3-868216134915Q39241971-27A39798-47EE-4D8A-9ECA-2773C6DE2490Q41338167-5F620086-24DD-4927-8264-54DC807CD82DQ41835487-F45CB4AF-EE6C-41B9-A6AB-2E158554A751Q41849265-81AA1E20-25EE-4F71-AD6A-5934A98FEEA6Q41949903-6DDB885D-18F6-4580-A3AF-2D5EA06326FAQ42019375-F3897749-E150-4EAD-942B-88E748BA9A33Q42046896-D6109837-5441-451D-BBD5-9AB6599E0E39Q42221852-59A964D0-CB14-4A07-A7D3-15554A8FE77AQ42974492-592FA29D-E481-4CAF-B86C-68CC12545E08Q43169814-74EF09A6-F380-4097-80CF-6D0E37D26FDFQ43192912-0738B4E7-0B38-4C28-99F3-B39AA5A0C368Q47437537-D00068B9-97B8-4EDE-953D-C09460B99294Q52608764-C31EFC14-942A-4B65-9178-8BBDCC7A6EA3Q54983373-C0782772-546B-4A8C-AF35-3087B2224DCBQ55432885-56EA4986-A6B9-48FD-8ED7-2D981CEE002B
P2860
The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.
description
1996 nî lūn-bûn
@nan
1996 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
The non-xanthine heterocyclic ...... adenosine receptor antagonist.
@ast
The non-xanthine heterocyclic ...... adenosine receptor antagonist.
@en
The non-xanthine heterocyclic ...... adenosine receptor antagonist.
@nl
type
label
The non-xanthine heterocyclic ...... adenosine receptor antagonist.
@ast
The non-xanthine heterocyclic ...... adenosine receptor antagonist.
@en
The non-xanthine heterocyclic ...... adenosine receptor antagonist.
@nl
prefLabel
The non-xanthine heterocyclic ...... adenosine receptor antagonist.
@ast
The non-xanthine heterocyclic ...... adenosine receptor antagonist.
@en
The non-xanthine heterocyclic ...... adenosine receptor antagonist.
@nl
P2093
P1476
The non-xanthine heterocyclic ...... adenosine receptor antagonist
@en
P2093
Baraldi PG
Dionisotti S
Monopoli A
Negretti A
P304
P407
P577
1996-02-01T00:00:00Z